Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)

Condition:   Cataract Interventions:   Drug: Clobetasol Propionate;   Drug: Vehicle Sponsor:   Salvat Not yet recruiting

Source: ClinicalTrials.gov - January 30, 2020 Category: Research Source Type: clinical trials